183 related articles for article (PubMed ID: 38671941)
1. Cord Blood Adductomics Reveals Oxidative Stress Exposure Pathways of Bronchopulmonary Dysplasia.
Lin ET; Bae Y; Birkett R; Sharma AM; Zhang R; Fisch KM; Funk W; Mestan KK
Antioxidants (Basel); 2024 Apr; 13(4):. PubMed ID: 38671941
[TBL] [Abstract][Full Text] [Related]
2. Untargeted adductomics of Cys34 modifications to human serum albumin in newborn dried blood spots.
Yano Y; Grigoryan H; Schiffman C; Edmands W; Petrick L; Hall K; Whitehead T; Metayer C; Dudoit S; Rappaport S
Anal Bioanal Chem; 2019 Apr; 411(11):2351-2362. PubMed ID: 30783713
[TBL] [Abstract][Full Text] [Related]
3. Protein Adductomics: Methodologies for Untargeted Screening of Adducts to Serum Albumin and Hemoglobin in Human Blood Samples.
Carlsson H; Rappaport SM; Törnqvist M
High Throughput; 2019 Mar; 8(1):. PubMed ID: 30857166
[TBL] [Abstract][Full Text] [Related]
4. Human Serum Albumin Cys34 Adducts in Newborn Dried Blood Spots: Associations With Air Pollution Exposure During Pregnancy.
Funk WE; Montgomery N; Bae Y; Chen J; Chow T; Martinez MP; Lurmann F; Eckel SP; McConnell R; Xiang AH
Front Public Health; 2021; 9():730369. PubMed ID: 35004563
[No Abstract] [Full Text] [Related]
5. Association of Chorioamnionitis With Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review, Meta-analysis, and Metaregression.
Villamor-Martinez E; Álvarez-Fuente M; Ghazi AMT; Degraeuwe P; Zimmermann LJI; Kramer BW; Villamor E
JAMA Netw Open; 2019 Nov; 2(11):e1914611. PubMed ID: 31693123
[TBL] [Abstract][Full Text] [Related]
6. Variations in Umbilical Cord Hematopoietic and Mesenchymal Stem Cells With Bronchopulmonary Dysplasia.
Chaudhury S; Saqibuddin J; Birkett R; Falcon-Girard K; Kraus M; Ernst LM; Grobman W; Mestan KK
Front Pediatr; 2019; 7():475. PubMed ID: 31799226
[No Abstract] [Full Text] [Related]
7. Untargeted adductomics of newborn dried blood spots identifies modifications to human serum albumin associated with childhood leukemia.
Yano Y; Schiffman C; Grigoryan H; Hayes J; Edmands W; Petrick L; Whitehead T; Metayer C; Dudoit S; Rappaport S
Leuk Res; 2020 Jan; 88():106268. PubMed ID: 31760269
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic Factors in Cord Blood of Preterm Infants Predicts Subsequently Developing Bronchopulmonary Dysplasia.
Yang WC; Chen CY; Chou HC; Hsieh WS; Tsao PN
Pediatr Neonatol; 2015 Dec; 56(6):382-5. PubMed ID: 25997993
[TBL] [Abstract][Full Text] [Related]
9. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
[TBL] [Abstract][Full Text] [Related]
10. Nutritional support during the first week for infants with bronchopulmonary dysplasia and respiratory distress: a multicenter cohort study in China.
Lin H; Bai G; Ge J; Chen X; He X; Ma X; Shi L; Du L; Chen Z
BMC Pediatr; 2024 Apr; 24(1):238. PubMed ID: 38570780
[TBL] [Abstract][Full Text] [Related]
11. Adductomics: a promising tool for the verification of chemical warfare agents' exposures in biological samples.
Golime R; Chandra B; Palit M; Dubey DK
Arch Toxicol; 2019 Jun; 93(6):1473-1484. PubMed ID: 30923868
[TBL] [Abstract][Full Text] [Related]
12. Overview of Adductomics in Toxicology.
Lockridge O
Curr Protoc; 2023 Feb; 3(2):e672. PubMed ID: 36799690
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network.
Ramos-Navarro C; Maderuelo-Rodríguez E; Concheiro-Guisán A; Pérez-Tarazona S; Rueda-Esteban S; Sánchez-Torres A; Sánchez-Solís M; Sanz-López E; Sánchez-Luna M;
Eur J Pediatr; 2022 Feb; 181(2):789-799. PubMed ID: 34596741
[TBL] [Abstract][Full Text] [Related]
14. Adductomics: characterizing exposures to reactive electrophiles.
Rappaport SM; Li H; Grigoryan H; Funk WE; Williams ER
Toxicol Lett; 2012 Aug; 213(1):83-90. PubMed ID: 21501670
[TBL] [Abstract][Full Text] [Related]
15. Association of serum angiogenic factors with bronchopulmonary dysplasia. The ANGIODYS cohort study.
Torchin H; Combarel D; Aubelle MS; Lopez C; Dubray L; El Ayoubi M; Tsatsaris V; Jarreau PH; Guibourdenche J; Zana-Taïeb E
Pregnancy Hypertens; 2019 Oct; 18():82-87. PubMed ID: 31577982
[TBL] [Abstract][Full Text] [Related]
16. Superoxide dismutase for bronchopulmonary dysplasia in preterm infants.
Albertella M; Gentyala RR; Paraskevas T; Ehret D; Bruschettini M; Soll R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013232. PubMed ID: 37811631
[TBL] [Abstract][Full Text] [Related]
17. Monocyte signature as a predictor of chronic lung disease in the preterm infant.
Windhorst AC; Heydarian M; Schwarz M; Oak P; Förster K; Frankenberger M; Gonzalez Rodriguez E; Zhang X; Ehrhardt H; Hübener C; Flemmer AW; Hossain H; Stoeger T; Schulz C; Hilgendorff A
Front Immunol; 2023; 14():1112608. PubMed ID: 37090732
[TBL] [Abstract][Full Text] [Related]
18. Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life.
Fritz AS; Keller T; Kribs A; Hünseler C
Eur J Pediatr; 2023 Jul; 182(7):3075-3082. PubMed ID: 37072630
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid signature of preterm infants developing bronchopulmonary dysplasia.
Romijn M; Onland W; van Keulen BJ; Heijboer AC; Rotteveel J; van Kaam AH; Finken MJJ
Pediatr Res; 2023 Nov; 94(5):1804-1809. PubMed ID: 37355738
[TBL] [Abstract][Full Text] [Related]
20. Preeclampsia and the Risk of Bronchopulmonary Dysplasia in Preterm Infants Less Than 32 Weeks' Gestation.
Soliman N; Chaput K; Alshaikh B; Yusuf K
Am J Perinatol; 2017 May; 34(6):585-592. PubMed ID: 27919118
[No Abstract] [Full Text] [Related]
[Next] [New Search]
